NCT07909031
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07909031
Title CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors (APOLLO)
Acronym APOLLO
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Crescent Biopharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.